Harrison James D, Choy Ellis T, Spillane Andrew, Butow Phyllis, Young Jane M, Evans Alison
Surgical Outcomes Research Centre, Sydney South West Area Health Service, University of Sydney, Sydney, NSW, Australia.
Breast. 2008 Aug;17(4):335-40. doi: 10.1016/j.breast.2008.03.001. Epub 2008 May 1.
Australian breast cancer specialists' involvement in multidisciplinary team (MDT) treatment planning meetings was ascertained in a cross sectional survey. The format of MDT meetings was also investigated. Medical specialists were regular attendees (>or=78%) compared to allied health staff and psychologists (<or=28%). Clinicians based in a major city (AOR 1.90; 95%CI: 1.01-3.58) and who treated >or=50 new cases a year (AOR 7.34; 95%CI: 3.38-15.96) were more likely to attend. Over 69% reported that the proportion of time devoted to case discussions was >or=75%. Topics always discussed were pathology, extent of disease, surgery performed and a treatment plan (>or=83%). The majority of respondents stated that MDT meetings were effective and improved referrals. Suggested improvements included that all key personnel attend, meetings are structured and that the views of all be heard. Work is needed to ensure MDT's function and co-operate as intended in treatment planning meetings.
通过一项横断面调查确定了澳大利亚乳腺癌专家参与多学科团队（MDT）治疗计划会议的情况。同时还对MDT会议的形式进行了调查。与专职医疗人员和心理学家相比（出席率≤28%），医学专家是常规参会者（出席率≥78%）。在大城市工作的临床医生（比值比1.90；95%置信区间：1.01 - 3.58）以及每年治疗≥50例新病例的临床医生（比值比7.34；95%置信区间：3.38 - 15.96）更有可能出席会议。超过69%的人报告称用于病例讨论的时间比例≥75%。总是讨论的主题包括病理学、疾病范围、所实施的手术和治疗计划（≥83%）。大多数受访者表示MDT会议是有效的，并且改善了转诊情况。建议的改进措施包括所有关键人员都要出席、会议要有组织架构以及要听取所有人的意见。需要开展工作以确保MDT在治疗计划会议中按预期发挥作用并进行协作。
